Navigation Links
Japan Esophagoscopes & Gastroscopes Market Outlook to 2020
Date:8/26/2014

ed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size data for Esophagoscopes & Gastroscopes market segments - Flexible Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible Video Gastroscopes.
- Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
- 2013 company shares and distribution shares data for Esophagoscopes & Gastroscopes market.
- Global corporate-level profiles of key companies operating within the Japan Esophagoscopes & Gastroscopes market.
- Key players covered include Olympus Corporation, Hoya Corporation, Fujifilm Holdings Corporation and KARL STORZ GmbH & Co. KG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's
'/>"/>

SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Empire Genomics Chooses Funakoshi as Japan Distributor
2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
3. Accuray Rolls Out Comprehensive Customer Service Program in Japan
4. CPhI Japan Triumphs in the Prestigious AEO Excellence Awards
5. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
6. Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
7. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
8. CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica
9. Japan Pharma Review: Outlook to 2017
10. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
11. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)...  CytRx Corporation (Nasdaq: CYTR ), a ... today announced an interim analysis from its two ... with either gemcitabine or ifosfamide. Both studies combine ... doses of aldoxorubicin. The combinations appear to be ... level of aldoxorubicin (170 mg/m2), impressive tumor responses ...
(Date:5/4/2015)... May 4, 2015  Geneia, a company of ... solutions to improve healthcare efficiencies, today announced a ... Center (BNRC) use Geneia,s advanced analytics solution ... the quality and lower the cost of patient ... outcomes, claims and utilization data from multiple sources ...
(Date:5/4/2015)... INDIANAPOLIS , May 4, 2015 ... released two new reports that provide a comprehensive ... reports highlight how Lilly is evolving its approach ... and capabilities in partnership with others to have ... 2014 Corporate Responsibility Update offers a thorough ...
Breaking Medicine Technology:CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Lilly Releases Corporate Responsibility, Global Health Reports 2Lilly Releases Corporate Responsibility, Global Health Reports 3Lilly Releases Corporate Responsibility, Global Health Reports 4
... , , BERLIN ... NKTR ) presented favorable data today on lead oncology program, ... investigational compound in ovarian cancer. These data were presented at ... Oncology (ESMO) 2009 Joint Multidisciplinary Congress in Berlin, Germany. , ...
... , , , ... a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase ... partial response rate and 50 percent stabilization rate in patients with metastatic ... at the joint 15th Congress of the European CanCer Organisation and 34th ...
Cached Medicine Technology:NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 2NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 3NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 4NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 5Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 2Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 3Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 4
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Unlike some camps, the ... imparting knowledge. The goal is to educate first and train ... This ensures that the young runners are building the knowledge ... A few of the topics covered include Effort Based Training, Running ... I used to be? This is not a camp where ...
(Date:5/4/2015)... Pa. (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen ... the hopes that it would remind others in similar situations ... A Recovery from Chronic Pain and Discovery of New Energy” ... with a new audience via a renewed press campaign. , ... with debilitating pain ,” Hawthorn-Deppen says. “As an adolescent ...
(Date:5/4/2015)... “ Food Cost Calculator ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... manage and efficiently calculate food costs. , The restaurant industry ... the industry has an estimated 1.8 trillion dollar impact on ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “St. Louis ... the “Gateway to the West,” so it is the ... Veterans Program”, says Dr. Ben Litalien, Chief Development Officer ... Association’s VetFran program and will provide veterans with a ... Zerorez® is proud to have a number of Military ...
Breaking Medicine News(10 mins):Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3
... Fewer Kidneys ,Kidney Donations by the Poor Are on ... with low incomes are more likely to develop kidney failure ... than people of other socioeconomic classes. Because fewer individuals in ... Hospital, University of British Columbia, in Vancouver, Canada) and colleagues ...
... HealthDay Reporter , FRIDAY, Nov. 19 (HealthDay News) -- Computer ... they,ll look after a "nose job," and the majority value ... The "morphing" software, used by plastic surgeons since the 1990s, ... study said. "Having an image of an individual in ...
... (HealthDay News) -- Male teens with disruptive behavior disorders ... in a traffic crash, either as a driver or ... risk is similar to that of epilepsy patients, said ... Canada, and his colleagues. Disruptive behavior disorders include ...
... By Ellin Holohan HealthDay Reporter , ... people ride motorcycles without wearing helmets in the United ... crashes are creating huge medical costs, two new companion ... all traumatic brain injuries sustained in motorcycle crashes involving ...
... 16, 2010) A clinical trial that aims to speed ... of breast cancer now has a designated study site ... University of Colorado Hospital. This study, called I-SPY ... Response with Imaging and Molecular Analysis 2) will evaluate ...
... medicine is a new lead in the search for compounds ... findings, reported by Vanderbilt University Medical Center researchers in the ... fresh approach for developing therapeutics that target the pathway. More ... second deadliest type of cancer in the developed world ...
Cached Medicine News:Health News:Efforts needed to address disparities in kidney transplantation 2Health News:Efforts needed to address disparities in kidney transplantation 3Health News:Efforts needed to address disparities in kidney transplantation 4Health News:Computer Imaging Adds to 'Nose Job' Satisfaction: Study 2Health News:Computer Imaging Adds to 'Nose Job' Satisfaction: Study 3Health News:Behavior Disorders Boost Crash Risk for Teen Boys: Study 2Health News:Young Motorcycle Riders Suffering More Brain Injuries 2Health News:Young Motorcycle Riders Suffering More Brain Injuries 3Health News:I-SPY 2 study speeds up treatment for breast cancer 2Health News:I-SPY 2 study speeds up treatment for breast cancer 3Health News:New path for colon cancer drug discovery 2
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 110o. Most popular size or model....
10 mm angled tip with indentation on side and gently curved blade. Round knurled handle with polished finish. Indentation: left side....
0.5 mm x 15 mm angled round blade with smoothly pointed tip and gently curved blade. Round knurled handle with polished finish....
Medicine Products: